Financial Ratios C-Rad AB BOERSE MUENCHEN
Stocks
24C
SE0002016352
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.330 EUR | +0.30% |
|
+1.84% | +14.68% |
| 06-18 | Affärsvärlden lists seven stocks to daydream about over the Midsummer holiday | FW |
| 06-16 | C-Rad executive purchases shares worth nearly SEK 0.4m | FW |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 7.92 | 4.21 | 8.36 | 9.84 | 7.66 | |||||
Return on Total Capital | 10.15 | 5.55 | 11.84 | 14.36 | 10.87 | |||||
Return On Equity % | 11.65 | 3.16 | 13.83 | 18.94 | 3.11 | |||||
Return on Common Equity | 11.65 | 3.16 | 13.83 | 18.94 | 3.11 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 65.18 | 68.13 | 67.64 | 68.87 | 71.52 | |||||
SG&A Margin | 47.55 | 59.44 | 54.02 | 51.79 | 55.6 | |||||
EBITDA Margin % | 15.08 | 7.95 | 13.03 | 15.25 | 14.06 | |||||
EBITA Margin % | 14.65 | 7.52 | 12.74 | 15.02 | 13.73 | |||||
EBIT Margin % | 14 | 7.22 | 11.73 | 15.02 | 13.72 | |||||
Income From Continuing Operations Margin % | 9.61 | 2.48 | 8.37 | 12.04 | 2.37 | |||||
Net Income Margin % | 9.61 | 2.48 | 8.37 | 12.04 | 2.37 | |||||
Net Avail. For Common Margin % | 9.61 | 2.48 | 8.37 | 12.04 | 2.37 | |||||
Normalized Net Income Margin | 8.55 | 4.46 | 6.43 | 10.62 | 2.24 | |||||
Levered Free Cash Flow Margin | -0.69 | -2.67 | 3.04 | 2.76 | 8.61 | |||||
Unlevered Free Cash Flow Margin | -0.65 | -2.63 | 3.09 | 2.77 | 8.72 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.9 | 0.93 | 1.14 | 1.05 | 0.89 | |||||
Fixed Assets Turnover | 20.38 | 26.56 | 41.01 | 32.07 | 20.87 | |||||
Receivables Turnover (Average Receivables) | 3.32 | 2.98 | 3.82 | 3.34 | 2.75 | |||||
Inventory Turnover (Average Inventory) | 4.24 | 3.36 | 2.64 | 2.48 | 2.54 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 3.81 | 3.32 | 2.75 | 2.89 | 3.09 | |||||
Quick Ratio | 3.49 | 2.82 | 2.22 | 2.47 | 2.71 | |||||
Operating Cash Flow to Current Liabilities | 0.26 | 0.1 | 0.25 | 0.2 | 0.5 | |||||
Days Sales Outstanding (Average Receivables) | 109.83 | 122.65 | 95.65 | 109.56 | 132.9 | |||||
Days Outstanding Inventory (Average Inventory) | 86.16 | 108.77 | 138.33 | 147.34 | 143.76 | |||||
Average Days Payable Outstanding | 87.91 | 82.41 | 68.58 | 82.66 | 91.26 | |||||
Cash Conversion Cycle (Average Days) | 108.07 | 149.01 | 165.39 | 174.24 | 185.4 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 4.08 | 3 | 1.81 | 3.63 | 3.85 | |||||
Total Debt / Total Capital | 3.92 | 2.91 | 1.77 | 3.5 | 3.71 | |||||
LT Debt/Equity | 2.76 | 1.68 | 0.65 | 2.77 | 2.71 | |||||
Long-Term Debt / Total Capital | 2.65 | 1.63 | 0.63 | 2.67 | 2.61 | |||||
Total Liabilities / Total Assets | 24.65 | 28.49 | 33.13 | 33.59 | 30.66 | |||||
EBIT / Interest Expense | 237.44 | 108.25 | 147.81 | 537.61 | 76.08 | |||||
EBITDA / Interest Expense | 275.64 | 136.05 | 173.64 | 567.29 | 82.66 | |||||
(EBITDA - Capex) / Interest Expense | 267.68 | 130.54 | 161.45 | 560.66 | 72.13 | |||||
Total Debt / EBITDA | 0.22 | 0.27 | 0.08 | 0.16 | 0.2 | |||||
Net Debt / EBITDA | -2.66 | -4.19 | -2.13 | -1.87 | -2.4 | |||||
Total Debt / (EBITDA - Capex) | 0.23 | 0.28 | 0.09 | 0.16 | 0.23 | |||||
Net Debt / (EBITDA - Capex) | -2.74 | -4.37 | -2.29 | -1.89 | -2.75 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 17.83 | 15.38 | 40.92 | 10.45 | -5.78 | |||||
Gross Profit, 1 Yr. Growth % | 24.35 | 20.6 | 39.9 | 12.46 | -2.15 | |||||
EBITDA, 1 Yr. Growth % | 72.63 | -39.16 | 100.62 | 39.62 | -13.09 | |||||
EBITA, 1 Yr. Growth % | 76.01 | -40.8 | 105.76 | 40.97 | -13.89 | |||||
EBIT, 1 Yr. Growth % | 82.37 | -40.5 | 128.94 | 41.39 | -13.9 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 74.74 | -70.21 | 375.05 | 58.88 | -81.48 | |||||
Net Income, 1 Yr. Growth % | 74.74 | -70.21 | 375.05 | 58.88 | -81.48 | |||||
Normalized Net Income, 1 Yr. Growth % | 118.17 | -39.88 | 103.37 | 82.32 | -80.13 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 72.09 | -70.27 | 377.27 | 59.05 | -81.46 | |||||
Accounts Receivable, 1 Yr. Growth % | 59.78 | 9.5 | 10.25 | 40.62 | -3.89 | |||||
Inventory, 1 Yr. Growth % | -32.99 | 132.31 | 60.28 | -16.68 | -14.44 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -3.5 | -19.71 | 4.91 | 75.87 | 27.12 | |||||
Total Assets, 1 Yr. Growth % | 13.38 | 10.59 | 19.57 | 20.67 | 2.34 | |||||
Tangible Book Value, 1 Yr. Growth % | 16.76 | 5.37 | 11.88 | 19.85 | 6.85 | |||||
Common Equity, 1 Yr. Growth % | 15.67 | 4.96 | 11.81 | 19.84 | 6.85 | |||||
Cash From Operations, 1 Yr. Growth % | -1.51 | -46.66 | 244.51 | -9.91 | 136.32 | |||||
Capital Expenditures, 1 Yr. Growth % | -19.18 | -9.54 | 270.24 | -78.84 | 865.59 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -58.09 | 348.6 | -260.69 | -0.02 | 195.14 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -59.63 | 366.64 | -265.9 | -1 | 197.12 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 12.76 | 16.6 | 27.51 | 24.76 | 2.02 | |||||
Gross Profit, 2 Yr. CAGR % | 15.43 | 22.46 | 29.9 | 25.43 | 4.9 | |||||
EBITDA, 2 Yr. CAGR % | 144.82 | 2.48 | 18.54 | 61.04 | 10.13 | |||||
EBITA, 2 Yr. CAGR % | 121.24 | 2.08 | 18.87 | 63.72 | 10.18 | |||||
EBIT, 2 Yr. CAGR % | 103.69 | 4.17 | 16.72 | 79.91 | 10.33 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 34.87 | -27.84 | 18.97 | 174.73 | -45.75 | |||||
Net Income, 2 Yr. CAGR % | 34.87 | -27.84 | 18.97 | 174.73 | -45.75 | |||||
Normalized Net Income, 2 Yr. CAGR % | 77.32 | 14.52 | 10.57 | 92.55 | -39.81 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 28.24 | -28.47 | 19.12 | 175.52 | -45.69 | |||||
Accounts Receivable, 2 Yr. CAGR % | 65.83 | 32.27 | 9.87 | 24.51 | 16.25 | |||||
Inventory, 2 Yr. CAGR % | 7.32 | 24.77 | 92.96 | 15.56 | -15.57 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 60.16 | -11.98 | -8.22 | 35.83 | 49.52 | |||||
Total Assets, 2 Yr. CAGR % | 39.42 | 11.97 | 14.99 | 20.12 | 11.13 | |||||
Tangible Book Value, 2 Yr. CAGR % | 69.79 | 10.92 | 8.58 | 15.8 | 13.17 | |||||
Common Equity, 2 Yr. CAGR % | 66.52 | 10.18 | 8.33 | 15.76 | 13.16 | |||||
Cash From Operations, 2 Yr. CAGR % | 7.14 | -27.52 | 35.55 | 76.18 | 45.92 | |||||
Capital Expenditures, 2 Yr. CAGR % | -32.65 | -14.5 | 83.01 | -11.48 | 42.95 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -46.83 | 37.12 | 168.49 | 26.76 | 71.53 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -47.95 | 37.24 | 178.24 | 28.16 | 71.26 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 11.16 | 13.63 | 24.2 | 21.55 | 13.61 | |||||
Gross Profit, 3 Yr. CAGR % | 14.45 | 17.13 | 28.02 | 23.8 | 15.47 | |||||
EBITDA, 3 Yr. CAGR % | 100.67 | 53.92 | 34.37 | 22.01 | 31.09 | |||||
EBITA, 3 Yr. CAGR % | 117.33 | 42.57 | 35.49 | 22.56 | 32.15 | |||||
EBIT, 3 Yr. CAGR % | 138.54 | 35.15 | 35.44 | 24.42 | 40.73 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 5.81 | -18.47 | 35.24 | 31.01 | 11.82 | |||||
Net Income, 3 Yr. CAGR % | 5.81 | -18.47 | 35.24 | 31.01 | 11.82 | |||||
Normalized Net Income, 3 Yr. CAGR % | 513.2 | 23.64 | 38.68 | 30.63 | -9.68 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 2.86 | -21.22 | 34.66 | 31.17 | 12.07 | |||||
Accounts Receivable, 3 Yr. CAGR % | 29.67 | 44.41 | 24.48 | 19.29 | 14.22 | |||||
Inventory, 3 Yr. CAGR % | 13.87 | 38.83 | 35.63 | 45.85 | 4.54 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 114.58 | 27.23 | -6.67 | 14 | 32.86 | |||||
Total Assets, 3 Yr. CAGR % | 27.89 | 29.06 | 14.45 | 16.85 | 13.87 | |||||
Tangible Book Value, 3 Yr. CAGR % | 36.5 | 44.83 | 11.24 | 12.21 | 12.74 | |||||
Common Equity, 3 Yr. CAGR % | 35.14 | 42.78 | 10.72 | 12.04 | 12.71 | |||||
Cash From Operations, 3 Yr. CAGR % | 23.67 | -15.09 | 21.86 | 18.3 | 94.3 | |||||
Capital Expenditures, 3 Yr. CAGR % | 69.67 | -25.69 | 39.36 | -10.84 | 96.32 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -29.08 | 8.25 | 44.57 | 93.17 | 67.84 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -30.36 | 8.12 | 46.2 | 97.16 | 69.46 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 25.87 | 17.75 | 17.44 | 17.96 | 14.8 | |||||
Gross Profit, 5 Yr. CAGR % | 27.83 | 19.86 | 20.39 | 20.38 | 18.22 | |||||
EBITDA, 5 Yr. CAGR % | 6.99 | 29.63 | 62.57 | 61.21 | 22.19 | |||||
EBITA, 5 Yr. CAGR % | 5.34 | 21.39 | 70.73 | 55.22 | 22.78 | |||||
EBIT, 5 Yr. CAGR % | 3.67 | 17.7 | 79.22 | 51.54 | 24.78 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -4.26 | -7.27 | 10.89 | 32.54 | -6.15 | |||||
Net Income, 5 Yr. CAGR % | -4.26 | -7.27 | 10.89 | 32.54 | -6.15 | |||||
Normalized Net Income, 5 Yr. CAGR % | 2.75 | 14.52 | 209.04 | 47.61 | -0.68 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -9.43 | -9.88 | 9.08 | 29.99 | -6.35 | |||||
Accounts Receivable, 5 Yr. CAGR % | 21.49 | 35.15 | 21.36 | 36.09 | 21.12 | |||||
Inventory, 5 Yr. CAGR % | 22.05 | 14.76 | 40.62 | 29.01 | 12.21 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 30.41 | 36.39 | 52.77 | 30.6 | 12.69 | |||||
Total Assets, 5 Yr. CAGR % | 24.61 | 23.5 | 22.57 | 25.4 | 13.11 | |||||
Tangible Book Value, 5 Yr. CAGR % | 28.53 | 29.16 | 24.56 | 32.43 | 12 | |||||
Common Equity, 5 Yr. CAGR % | 26.76 | 27.71 | 23.7 | 31.28 | 11.69 | |||||
Cash From Operations, 5 Yr. CAGR % | -16.45 | 19.24 | 28.29 | 13.7 | 30.97 | |||||
Capital Expenditures, 5 Yr. CAGR % | 18.9 | 4.9 | 74.88 | -20.3 | 40.79 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -46.61 | 0.76 | 20.79 | 15.3 | 54.8 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -47.19 | 0.44 | 21.2 | 15.73 | 55.75 |
- Stock Market
- Stocks
- CRAD B Stock
- 24C Stock
- Financials C-Rad AB
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















